231 related articles for article (PubMed ID: 23856419)
1. Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs.
Bigg PW; Baldo G; Sleeper MM; O'Donnell PA; Bai H; Rokkam VR; Liu Y; Wu S; Giugliani R; Casal ML; Haskins ME; Ponder KP
Mol Genet Metab; 2013 Nov; 110(3):319-28. PubMed ID: 23856419
[TBL] [Abstract][Full Text] [Related]
2. The effect of neonatal gene therapy with a gamma retroviral vector on cardiac valve disease in mucopolysaccharidosis VII dogs after a decade.
Bigg PW; Sleeper MM; O'Donnell PA; Liu Y; Wu S; Casal ML; Haskins ME; Ponder KP
Mol Genet Metab; 2013 Nov; 110(3):311-8. PubMed ID: 23860311
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII.
Sleeper MM; Fornasari B; Ellinwood NM; Weil MA; Melniczek J; O'Malley TM; Sammarco CD; Xu L; Ponder KP; Haskins ME
Circulation; 2004 Aug; 110(7):815-20. PubMed ID: 15289379
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression.
Metcalf JA; Linders B; Wu S; Bigg P; O'Donnell P; Sleeper MM; Whyte MP; Haskins M; Ponder KP
Mol Genet Metab; 2010 Apr; 99(4):396-407. PubMed ID: 20044292
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII.
Smith LJ; Baldo G; Wu S; Liu Y; Whyte MP; Giugliani R; Elliott DM; Haskins ME; Ponder KP
Mol Genet Metab; 2012 Sep; 107(1-2):153-60. PubMed ID: 22513347
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs.
Ponder KP; Melniczek JR; Xu L; Weil MA; O'Malley TM; O'Donnell PA; Knox VW; Aguirre GD; Mazrier H; Ellinwood NM; Sleeper M; Maguire AM; Volk SW; Mango RL; Zweigle J; Wolfe JH; Haskins ME
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13102-7. PubMed ID: 12232044
[TBL] [Abstract][Full Text] [Related]
7. Effect of neonatal gene therapy on lumbar spine disease in mucopolysaccharidosis VII dogs.
Smith LJ; Martin JT; O'Donnell P; Wang P; Elliott DM; Haskins ME; Ponder KP
Mol Genet Metab; 2012 Sep; 107(1-2):145-52. PubMed ID: 22510705
[TBL] [Abstract][Full Text] [Related]
8. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.
Mango RL; Xu L; Sands MS; Vogler C; Seiler G; Schwarz T; Haskins ME; Ponder KP
Mol Genet Metab; 2004 May; 82(1):4-19. PubMed ID: 15110316
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation.
Baldo G; Wu S; Howe RA; Ramamoothy M; Knutsen RH; Fang J; Mecham RP; Liu Y; Wu X; Atkinson JP; Ponder KP
Mol Genet Metab; 2011 Dec; 104(4):608-19. PubMed ID: 21944884
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII.
Gurda BL; De Guilhem De Lataillade A; Bell P; Zhu Y; Yu H; Wang P; Bagel J; Vite CH; Sikora T; Hinderer C; Calcedo R; Yox AD; Steet RA; Ruane T; O'Donnell P; Gao G; Wilson JM; Casal M; Ponder KP; Haskins ME
Mol Ther; 2016 Feb; 24(2):206-216. PubMed ID: 26447927
[TBL] [Abstract][Full Text] [Related]
11. Large proteoglycan complexes and disturbed collagen architecture in the corneal extracellular matrix of mucopolysaccharidosis type VII (Sly syndrome).
Young RD; Liskova P; Pinali C; Palka BP; Palos M; Jirsova K; Hrdlickova E; Tesarova M; Elleder M; Zeman J; Meek KM; Knupp C; Quantock AJ
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6720-8. PubMed ID: 21743015
[TBL] [Abstract][Full Text] [Related]
12. The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade.
Xing EM; Knox VW; O'Donnell PA; Sikura T; Liu Y; Wu S; Casal ML; Haskins ME; Ponder KP
Mol Genet Metab; 2013 Jun; 109(2):183-93. PubMed ID: 23628461
[TBL] [Abstract][Full Text] [Related]
13. Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs.
Wang B; O'Malley TM; Xu L; Vite C; Wang P; O'Donnell PA; Ellinwood NM; Haskins ME; Ponder KP
Mol Genet Metab; 2006 Jan; 87(1):8-21. PubMed ID: 16275036
[TBL] [Abstract][Full Text] [Related]
14. Delayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogs.
Peck SH; O'Donnell PJ; Kang JL; Malhotra NR; Dodge GR; Pacifici M; Shore EM; Haskins ME; Smith LJ
Mol Genet Metab; 2015 Nov; 116(3):195-203. PubMed ID: 26422116
[TBL] [Abstract][Full Text] [Related]
15. Effects of bone marrow transplantation on the cardiovascular abnormalities in canine mucopolysaccharidosis VII.
Sammarco C; Weil M; Just C; Weimelt S; Hasson C; O'Malley T; Evans SM; Wang P; Casal ML; Wolfe J; Haskins M
Bone Marrow Transplant; 2000 Jun; 25(12):1289-97. PubMed ID: 10871735
[TBL] [Abstract][Full Text] [Related]
16. Clinical response to persistent, low-level beta-glucuronidase expression in the murine model of mucopolysaccharidosis type VII.
Donsante A; Levy B; Vogler C; Sands MS
J Inherit Metab Dis; 2007 Apr; 30(2):227-38. PubMed ID: 17308887
[TBL] [Abstract][Full Text] [Related]
17. The effect of Tlr4 and/or C3 deficiency and of neonatal gene therapy on skeletal disease in mucopolysaccharidosis VII mice.
Xing EM; Wu S; Ponder KP
Mol Genet Metab; 2015 Feb; 114(2):209-16. PubMed ID: 25559179
[TBL] [Abstract][Full Text] [Related]
18. Corrective GUSB transfer to the canine mucopolysaccharidosis VII cornea using a helper-dependent canine adenovirus vector.
Serratrice N; Cubizolle A; Ibanes S; Mestre-Francés N; Bayo-Puxan N; Creyssels S; Gennetier A; Bernex F; Verdier JM; Haskins ME; Couderc G; Malecaze F; Kalatzis V; Kremer EJ
J Control Release; 2014 May; 181():22-31. PubMed ID: 24607662
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral vector-mediated beta-glucuronidase cDNA transfer to treat MPS VII RPE in vitro.
Verdugo ME; Scarpino V; Moullier P; Haskins ME; Aguirre GD; Ray J
Curr Eye Res; 2001 Nov; 23(5):357-67. PubMed ID: 11910525
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.
Xu L; Mango RL; Sands MS; Haskins ME; Ellinwood NM; Ponder KP
Mol Ther; 2002 Dec; 6(6):745-58. PubMed ID: 12498771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
